Utility of routine laboratory tests in the assessment of chronic venous disease progression in female patients

Matei,Sergiu-Ciprian; Matei,Mervat; Anghel,Flavia Medana; Carabenciov,Emma; Murariu,Marius-Sorin; Olariu,Sorin

doi:10.3892/etm.2022.11508

Utility of routine laboratory tests in the assessment of chronic venous disease progression in female patients

Authors:
- Sergiu-Ciprian Matei
- Mervat Matei
- Flavia Medana Anghel
- Emma Carabenciov
- Marius-Sorin Murariu
- Sorin Olariu
View Affiliations

Affiliations: Department X of Surgery, ‘Victor Babeș’ University of Medicine and Pharmacy Timișoara, Timișoara 300041, Romania
Published online on: July 14, 2022 https://doi.org/10.3892/etm.2022.11508
Article Number: 571
Copyright: © Matei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic venous disease (CVD) is a frequently encountered disease that progresses with age. Although the principal method of evaluation and diagnosis is Doppler ultrasound, routine laboratory tests may be an easier and more accessible way to evaluate CVD progression. The present retrospective study evaluated the laboratory results of 256 patients diagnosed with CVD. According to the Clinical, Etiological, Anatomical and Pathophysiological classification, depending on the CVD stage, patients were stratified into three groups: Group 1 (C2‑C3; mild disease), Group 2 (C4; moderate to severe disease) and Group 3 (C5‑C6; severe disease). The considered parameters were age, red blood cell count (RBC), white blood cell count (WBC) and platelet count (PLT), percentage of neutrophils and lymphocytes, neutrophil‑to‑lymphocyte ratio (NLR), erythrocyte sedimentation rate (ESR), C‑reactive protein (CRP), fibrinogen, prothrombin time (in percentages and seconds), internal normalized ratio, activated partial thromboplastin time, creatine kinase (CK), CK myocardial band, alanine transaminase, aspartate transaminase, total bilirubin and urea. No significant differences among the groups were noted in RBC, WBC, PLT and coagulation factors; on the other hand, inflammatory markers exhibited differences among the groups. Several differences were observed in hepatic, metabolic and muscle tissue markers. Intraluminal thrombus formation in the case of varicose veins (thrombophlebitis) may be due to conditions of turbulent flow, stasis and endothelial inflammation, rather than hypercoagulability. The results of the present study confirmed the implication of inflammatory factors in pathophysiological modifications, including thickening of venous walls and valvular modification, as well as the appearance of intraluminal thrombi and trophic lesions. NLR, ESR, CRP and fibrinogen were increased with CVD progression and may be considered useful markers in evaluating CVD progression. Simple blood tests may provide phlebologists with additional insight for the management of those patients.

View Figures

View References

1	Branisteanu DE, Feodor T, Baila S, Mitea IA and Vittos O: Impact of chronic venous disease on quality of life: Results of vein alarm study. Exp Ther Med. 17:1091–1096. 2019.PubMed/NCBI View Article : Google Scholar
2	Raffetto JD and Mannello F: Pathophysiology of chronic venous disease. Int Angiol. 33:212–221. 2014.PubMed/NCBI
3	Feodor T, Baila S, Mitea IA, Branisteanu DE and Vittos O: Epidemiology and clinical characteristics of chronic venous disease in Romania. Exp Ther Med. 17:1097–1105. 2019.PubMed/NCBI View Article : Google Scholar
4	Andercou A, Forsea D, Petrovai IG, Tãnãsele R, Radulescu S, Tãtaru Al, Popescu S, Teodorescu M, Avram J, Petrescu Z, et al: SEPIA-an epidemiological study of the prevalence of chronic venous insufficiency among the outpatient population in Romania. Rom J Angiol Vasc Surg. 7(3)2005.
5	Glišić TM, Perišić MD, Dimitrijevic S and Jurišić V: Doppler assessment of splanchnic arterial flow in patients with liver cirrhosis: Correlation with ammonia plasma levels and MELD score. J Clin Ultrasound. 42:264–269. 2014.PubMed/NCBI View Article : Google Scholar
6	Santler B and Goerge T: Chronic venous insufficiency-a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 15:538–556. 2017.PubMed/NCBI View Article : Google Scholar
7	Kostas TI, Ioannou CV, Drygiannakis I, Georgakarakos E, Kounos C, Tsetis D and Katsamouris AN: Chronic venous disease progression and modification of predisposing factors. J Vasc Surg. 51:900–907. 2010.PubMed/NCBI View Article : Google Scholar
8	Yonekawa O: An accurate diagnosis is possible with a systematic analysis of routine laboratory data. Rinsho Byori. 63:1072–1079. 2015.PubMed/NCBI
9	Kruger PC, Eikelboom JW, Douketis JD and Hankey GJ: Deep vein thrombosis: Update on diagnosis and management. Med J Aust. 210:516–524. 2019.PubMed/NCBI View Article : Google Scholar
10	Karahan O, Yavuz C, Kankilic N, Demirtas S, Tezcan O, Caliskan A and Mavitas B: Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency. Blood Coagul Fibrinolysis. 27:684–690. 2016.PubMed/NCBI View Article : Google Scholar
11	Smith RK and Golledge J: A systematic review of circulating markers in primary chronic venous insufficiency. Phlebology. 29:570–579. 2014.PubMed/NCBI View Article : Google Scholar
12	Zegarra TI and Tadi P: CEAP classification of venous disorders. In: StatPearls. StatPearls Publishing, Treasure Island, FL, 2022.
13	Davies AH: The seriousness of chronic venous disease: A review of real-world evidence. Adv Ther. 36 (Suppl 1):5–12. 2019.PubMed/NCBI View Article : Google Scholar
14	Chen S, Liu Y, Cai L, Ren C, Xiong T, Jin L, Nong S, Chen Q, Li Y, Cong Y and Jiang H: Erythropoiesis changes with increasing age in the elderly Chinese. Int J Lab Hematol. 43:1168–1173. 2021.PubMed/NCBI View Article : Google Scholar
15	Kubota K, Shirakura T, Orui T, Muratani M, Maki T, Tamura J and Morita T: Changes in the blood cell counts with aging. Nihon Ronen Igakkai Zasshi. 28:509–514. 1991.PubMed/NCBI View Article : Google Scholar : (In Japanese).
16	Nunes CA, Melo PG, Malaquias SG, Amaral KV, Alves GR, Meira AA, Cardoso AL, Pereira LV and Bachion MM: Effectiveness of two bundles in venous leg ulcer healing: A randomized controlled trial. J VascNurs. 37:232–245. 2019.PubMed/NCBI View Article : Google Scholar
17	Mosmiller LT, Steele KN, Shrader CD and Petrone AB: Evaluation of inflammatory cell biomarkers in chronic venous insufficiency. Phlebology. 32:634–640. 2017.PubMed/NCBI View Article : Google Scholar
18	Lapić I, Padoan A, Bozzato D and Plebani M: Erythrocyte sedimentation rate and C-reactive protein in acute inflammation. Am J Clin Pathol. 153:14–29. 2020.PubMed/NCBI View Article : Google Scholar
19	Tishkowski K and Gupta V: Erythrocyte sedimentation rate. In: StatPearls. StatPearls Publishing, Treasure Island, FL, 2021.
20	Sproston NR and Ashworth JJ: Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 9(754)2018.PubMed/NCBI View Article : Google Scholar
21	Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Giovannini L, Palla R and Tetta C: C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif. 18:183–190. 2000.PubMed/NCBI View Article : Google Scholar
22	Camici M: C-reactive protein, atherosclerosis and cardiovascular disease. An update. Minerva Cardioangiol. 50:327–331. 2002.PubMed/NCBI
23	Tang Y, Fung E, Xu A and Lan HY: C-reactive protein and ageing. Clin Exp Pharmacol Physiol. 44 (Suppl 1):S9–S14. 2017.PubMed/NCBI View Article : Google Scholar
24	Gomez I, Benyahia C, Le Dall J, Payré C, Louedec L, Leséche G, Lambeau G, Longrois D and Norel X: Absence of inflammatory conditions in human varicose saphenous veins. Inflamm Res. 62:299–308. 2013.PubMed/NCBI View Article : Google Scholar
25	Ozturk S and Yetkin E: Increased inflammatory status in chronic venous insufficiency patients. Phlebology. 32:641–642. 2017.PubMed/NCBI View Article : Google Scholar
26	Raffetto JD: Pathophysiology of chronic venous disease and venous ulcers. Surg Clin North Am. 98:337–347. 2018.PubMed/NCBI View Article : Google Scholar
27	Jurisic V, Terzic T, Colic S and Jurisic M: The concentration of TNF-alpha correlate with number of inflammatory cells and degree of vascularization in radicular cysts. Oral Dis. 14:600–605. 2008.PubMed/NCBI View Article : Google Scholar
28	Jurisic V, Radenkovic S and Konjevic G: The actual role of LDH as tumor marker, biochemical and clinical aspects. Adv Exp Med Biol. 867:115–124. 2015.PubMed/NCBI View Article : Google Scholar
29	Poredos P, Spirkoska A, Rucigaj T, Fareed J and Jezovnik MK: Do blood constituents in varicose veins differ from the systemic blood constituents? Eur J Vasc Endovasc Surg. 50:250–256. 2015.PubMed/NCBI View Article : Google Scholar
30	Aleman MM, Walton BL, Byrnes JR and Wolberg AS: Fibrinogen and red blood cells in venous thrombosis. Thromb Res. 133 (Suppl 1):S38–S40. 2014.PubMed/NCBI View Article : Google Scholar
31	Kamphuisen PW, Eikenboom JC, Vos HL, Pablo R, Sturk A, Bertina RM and Rosendaal FR: Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost. 81:680–683. 1999.PubMed/NCBI
32	Moore K, Huddleston E, Stacey MC and Harding KG: Venous leg ulcers-the search for a prognostic indicator. Int Wound J. 4:163–172. 2007.PubMed/NCBI View Article : Google Scholar
33	Mosesson MW: Fibrinogen and fibrin structure and functions. J Thromb Haemost. 3:1894–1904. 2005.PubMed/NCBI View Article : Google Scholar
34	Blomgren L, Johansson G, Siegbahn A and Bergqvist D: Coagulation and fibrinolysis in chronic venous insufficiency. Vasa. 30:184–187. 2001.PubMed/NCBI View Article : Google Scholar
35	Dorgalaleh A, Favaloro EJ, Bahraini M and Rad F: Standardization of prothrombin time/international normalized ratio (PT/INR). Int J Lab Hematol. 43:21–28. 2021.PubMed/NCBI View Article : Google Scholar
36	Nasr H and Scriven JM: Superficial thrombophlebitis (superficial venous thrombosis). BMJ. 350(h2039)2015.PubMed/NCBI View Article : Google Scholar
37	Luis Rodríguez-Peralto J, Carrillo R, Rosales B and Rodríguez-Gil Y: Superficial thrombophlebitis. Semin Cutan Med Surg. 26:71–76. 2007.PubMed/NCBI View Article : Google Scholar
38	Kushner A, West WP and Pillarisetty LS: Virchow triad. In: StatPearls. StatPearls Publishing, Treasure Island, FL, 2021.
39	Cocoi AF, Pop D, Cocoi M, Serban AM and Vida-Simiti LA: Involvement of inflammatory markers in pathogenesis of venous thromboembolism. Rev Romana Med Lab. 25:227–236. 2017.
40	Rosalki SB: Low serum creatine kinase activity. Clin Chem. 44(905)1998.PubMed/NCBI
41	Bekkelund SI and Johnsen SH: Creatine kinase is associated with reduced inflammation in a general population: The Tromsø study. PLoS One. 13(e0198133)2018.PubMed/NCBI View Article : Google Scholar
42	Okonkwo UA and DiPietro LA: Diabetes and wound angiogenesis. Int J Mol Sci. 18(1419)2017.PubMed/NCBI View Article : Google Scholar
43	Eyth E, Basit H and Smith CJ: Glucose Tolerance Test. Updated. In: StatPearls. StatPearls Publishing, Treasure Island, FL, 2021.